Talisman Capital Partners has sold ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
ADVOCATE RCM is a provider of premium technology-enabled revenue cycle management (RCM) services for radiology and other facility-based physician specialties. Since 1998, Dublin, Ohio-based ADVOCATE RCM has invested substantial capital in technology and innovation, building a premier billing process that produces consistent and superior revenue results for its clients.
ADVOCATE RCM, a portfolio company of Talisman Capital Partners, was acquired by Ventra Health, a portfolio company of Varsity Healthcare Partners. Ventra Health is a leading provider of high-performance business solutions for physician practices, hospitals, health systems and ambulatory service centers with deep expertise in anesthesia, emergency medicine and hospital medicine. ADVOCATE RCM will operate as a division of Ventra Health, and the combined organization creates one of the nation’s largest, most sophisticated technology-enabled providers of end-to-end RCM services, offering clients access to industry-leading technology, data and analytics, patient engagement, payer contracting and automation tools.
Mike Siano, Lincoln International Managing Director who led the transaction, commented, “We are grateful and honored for the opportunity to have advised Talisman and ADVOCATE RCM on its new partnership with Ventra Health and Varsity Healthcare Partners. ADVOCATE RCM has established an innovative and differentiated offering in the radiology RCM segment, and we look forward to following the future success of the business as part of the broader Ventra Health platform.”
Lincoln International was selected to represent ADVOCATE RCM due to their demonstrated knowledge of our industry, their relationships with key target sponsors and their philosophy of running a narrow process with qualified investors and strategic partners. Lincoln did a phenomenal job at running the process itself, and also showcasing what makes Advocate a unique asset in the healthcare revenue cycle space. Our leadership team had not participated in a transaction of this size and scope, and Lincoln’s strategic advice was instrumental in guiding the representative team members and arriving at a favorable transaction for our shareholders.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised Seven Hills Capital on raising capital for Reliable Medical
Lincoln International advised CNS Cares, a portfolio company of Revelstoke Capital Partners, on completing a leveraged dividend recapitalization
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.